Ultra-processed food consumption and renal cell carcinoma incidence and mortality: results from a large prospective cohort.

IF 7 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL
Ya-Dong Li, Yong-Xin Fu, Le-Lan Gong, Ting Xie, Wei Tan, Hao Huang, Sheng-Jie Zeng, Chuan Liu, Zheng-Ju Ren
{"title":"Ultra-processed food consumption and renal cell carcinoma incidence and mortality: results from a large prospective cohort.","authors":"Ya-Dong Li, Yong-Xin Fu, Le-Lan Gong, Ting Xie, Wei Tan, Hao Huang, Sheng-Jie Zeng, Chuan Liu, Zheng-Ju Ren","doi":"10.1186/s12916-024-03677-5","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Growing evidence shows that ultra-processed food consumption is associated with the risk of cancer. However, prospective evidence is limited on renal cell carcinoma (RCC) incidence and mortality. In this study, we aimed to examine the association of ultra-processed food consumption and RCC incidence and mortality in a large cohort of US adults.</p><p><strong>Methods: </strong>A population-based cohort of 101,688 participants were included from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Ultra-processed food items were confirmed by using the NOVA food classification system. The consumption of ultra-processed food was expressed as a percentage of total food intake (g/day). Prospective associations were calculated using Cox regression. Restricted cubic spline regression was used to assess nonlinearity. Subgroup analyses were performed to investigate the potential effect modifiers on the incidence and mortality of RCC.</p><p><strong>Results: </strong>A total of 410 participants developed RCC during a total of 899,731 person-years of follow-up (median 9.41 years) and 230 RCC deaths during 1,533,930 person-years of follow-up (median 16.85 years). In the fully adjusted model, participants in the highest compared with the lowest quintiles of ultra-processed food consumption had a higher risk of RCC (HR quartile 4 vs 1:1.42; 95% CI: 1.06-1.91; P<sub>trend</sub> = 0.004) and mortality (HR quartile 4 vs. quartile 1: 1.64; 95% CI: 1.10-2.43; P<sub>trend</sub> = 0.027). Linear dose-response associations with RCC incidence and mortality were observed for ultra-processed food consumption (all P<sub>nonlinearity</sub> > 0.05). The reliability of these results was supported by sensitivity and subgroup analyses.</p><p><strong>Conclusion: </strong>In conclusion, higher consumption of ultra-processed food is associated with an increased risk of RCC incidence and mortality. Limiting ultra-processed food consumption might be a primary prevention method of RCC.</p>","PeriodicalId":9188,"journal":{"name":"BMC Medicine","volume":"22 1","pages":"459"},"PeriodicalIF":7.0000,"publicationDate":"2024-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11472506/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12916-024-03677-5","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Growing evidence shows that ultra-processed food consumption is associated with the risk of cancer. However, prospective evidence is limited on renal cell carcinoma (RCC) incidence and mortality. In this study, we aimed to examine the association of ultra-processed food consumption and RCC incidence and mortality in a large cohort of US adults.

Methods: A population-based cohort of 101,688 participants were included from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Ultra-processed food items were confirmed by using the NOVA food classification system. The consumption of ultra-processed food was expressed as a percentage of total food intake (g/day). Prospective associations were calculated using Cox regression. Restricted cubic spline regression was used to assess nonlinearity. Subgroup analyses were performed to investigate the potential effect modifiers on the incidence and mortality of RCC.

Results: A total of 410 participants developed RCC during a total of 899,731 person-years of follow-up (median 9.41 years) and 230 RCC deaths during 1,533,930 person-years of follow-up (median 16.85 years). In the fully adjusted model, participants in the highest compared with the lowest quintiles of ultra-processed food consumption had a higher risk of RCC (HR quartile 4 vs 1:1.42; 95% CI: 1.06-1.91; Ptrend = 0.004) and mortality (HR quartile 4 vs. quartile 1: 1.64; 95% CI: 1.10-2.43; Ptrend = 0.027). Linear dose-response associations with RCC incidence and mortality were observed for ultra-processed food consumption (all Pnonlinearity > 0.05). The reliability of these results was supported by sensitivity and subgroup analyses.

Conclusion: In conclusion, higher consumption of ultra-processed food is associated with an increased risk of RCC incidence and mortality. Limiting ultra-processed food consumption might be a primary prevention method of RCC.

超加工食品消费与肾细胞癌发病率和死亡率:大型前瞻性队列的结果。
背景:越来越多的证据表明,食用超加工食品与癌症风险有关。然而,有关肾细胞癌(RCC)发病率和死亡率的前瞻性证据却很有限。在这项研究中,我们的目的是在一个大型美国成年人队列中研究超标加工食品消费与肾细胞癌发病率和死亡率之间的关系:方法:我们从 "前列腺癌、肺癌、结肠直肠癌和卵巢癌筛查试验"(Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial)中选取了101,688名参与者组成人群队列。使用 NOVA 食品分类系统确认了超加工食品。超加工食品的摄入量以占总食物摄入量的百分比(克/天)表示。采用考克斯回归法计算前瞻性关联。限制性三次样条回归用于评估非线性。进行了分组分析,以研究RCC发病率和死亡率的潜在影响因素:在总共 899,731 人/年的随访期间(中位数为 9.41 年),共有 410 人患 RCC,在 1,533,930 人/年的随访期间(中位数为 16.85 年),共有 230 人死于 RCC。在完全调整模型中,与超加工食品消费量最低的五分位数相比,超加工食品消费量最高的五分位数参与者罹患 RCC 的风险更高(HR 四分位数 4 vs. 四分位数 1:1.42;95% CI:1.06-1.91;Ptrend = 0.004),死亡率也更高(HR 四分位数 4 vs. 四分位数 1:1.64;95% CI:1.10-2.43;Ptrend = 0.027)。超加工食品消费量与 RCC 发病率和死亡率呈线性剂量反应关系(所有 P 非线性均大于 0.05)。这些结果的可靠性得到了敏感性分析和亚组分析的支持:总之,摄入较多超标加工食品与 RCC 发病率和死亡率风险增加有关。限制超加工食品的摄入量可能是一种初级预防 RCC 的方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
BMC Medicine
BMC Medicine 医学-医学:内科
CiteScore
13.10
自引率
1.10%
发文量
435
审稿时长
4-8 weeks
期刊介绍: BMC Medicine is an open access, transparent peer-reviewed general medical journal. It is the flagship journal of the BMC series and publishes outstanding and influential research in various areas including clinical practice, translational medicine, medical and health advances, public health, global health, policy, and general topics of interest to the biomedical and sociomedical professional communities. In addition to research articles, the journal also publishes stimulating debates, reviews, unique forum articles, and concise tutorials. All articles published in BMC Medicine are included in various databases such as Biological Abstracts, BIOSIS, CAS, Citebase, Current contents, DOAJ, Embase, MEDLINE, PubMed, Science Citation Index Expanded, OAIster, SCImago, Scopus, SOCOLAR, and Zetoc.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信